Rare Mutation Detection with Digital PCR - ASHG 2014

Product manager Dr. Iain Russell spoke with us about the new QuantStudio 3D rare mutation analysis solution. The solution includes a subset of wet lab–validated TaqMan SNP Genotyping Assays to detect and quantify the most common cancer-related mutations (e.g., EGFR, BRAF, KRAS, PIK3CA, and JAK2) and is designed using the full bioinformatics power of the TaqMan Assay design pipeline. Wet lab–validated specifically for the QuantStudio 3D, researchers are now able to quantify rare mutants at a prevalence as low as 0.1%.